CardieX Announces A$6.5 Million Capital Raise to Boost Strategic Initiatives

CardieX ( (AU:CDX) ) has provided an announcement.

CardieX has announced a capital raise initiative to generate approximately A$6.5 million through the issuance of around 162.8 million new fully paid ordinary shares. This includes a placement to raise A$2.4 million and a 1 for 4 pro-rata non-renounceable entitlement offer of A$4.1 million. C2 Ventures, holding 30.2% of CardieX’s existing shares, will fully participate in the entitlement offer and placement, also sub-underwriting A$1.2 million of the entitlement offer. This capital raise is expected to enhance CardieX’s financial position and support its strategic initiatives in the health technology sector.

More about CardieX

CardieX operates in the health technology industry, focusing on digital vascular biomarkers to assess cardiovascular risk through arterial intelligence.

Average Trading Volume: 296,133

Technical Sentiment Signal: Sell

Current Market Cap: A$22.55M

For detailed information about CDX stock, go to TipRanks’ Stock Analysis page.